MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-03-0152309
Atrimed Pharmaceuticals Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹24.09 Cr
▼ 8% YoY
Net profit · FY 2024
₹2.81 Lakh
Net margin 0.1%
EBITDA · FY 2024
₹53.69 Lakh
EBITDA margin 2.2%
Authorised capital
₹8.5 Cr
Registered with MCA
Paid-up capital
₹8.16 Cr
Issued & subscribed
Open charges
₹2.41 Cr
Secured borrowings
Company age
23 yrs
Est. 2003
Employees · EPFO
132
Provident fund records
About Atrimed Pharmaceuticals Private Limited
Data last updated:
Atrimed Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 03 July 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U02423KA2003PTC032200. Its GSTIN is 29AAECA2885Q1ZW (Karnataka). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹8.5 Cr and a paid-up capital of ₹8.16 Cr. It was formerly known as Atrimed Herbals Private Limited. It is led by directors including Ganju Shibban Krishen and Hrishikesh Damle.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.755 3rd Cross 11th Block 2nd Stage Bda Layout Nagarbhavi Bangalore, Karnataka, India – 560072.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.09 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.81 Lakh (net margin 0.1%) and EBITDA of ₹53.69 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 2% over five years.
The company has about 132 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.41 Cr on record. Court records list 7 cases involving the company, including 4 filed by the company and 3 filed against it; 2 cases are pending.
Atrimed Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0152309). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website atrimed.com.
Company details
CIN U02423KA2003PTC032200
Registration Number 032200
Incorporation Date 03 July 2003
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0152309
Recognitions & Rankings of Atrimed Pharmaceuticals
Contact details
Atrimed Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is atrimed.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.755 3rd Cross 11th Block 2nd Stage Bda Layout Nagarbhavi Bangalore, Karnataka, India – 560072
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Atrimed Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Atrimed Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Atrimed Pharmaceuticals is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Atrimed Pharmaceuticals Private Limited, buy the company report.
Financials of Atrimed Pharmaceuticals Private Limited
FY 2025 filings availableAtrimed Pharmaceuticals Private Limited reported revenue of ₹24.09 Cr (down 8% YoY) for FY 2024.
Revenue · FY 2024
₹24.09 Cr ▼ 8%
Net profit · FY 2024
₹2.81 Lakh margin 0.1%
EBITDA · FY 2024
₹53.69 Lakh margin 2.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 2%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 29%
5 years · compounded
▼ 28%
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹53.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Atrimed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Atrimed Pharmaceuticals Private Limited
Atrimed Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganju Shibban Krishen | Director | 25 Mar 2010 | 16 Years 7 Months | Current |
| Hrishikesh Damle Also directs: Atrimed Bio-Tech LLP, Damle & Ganju Health Consultants LLP, Save A Mother Foundation and 3 more | Director | 03 Jul 2003 | 23 Years 3 Months | Current |
| Rishi Ganju | Director | 09 Sep 2021 | 5 Years 1 Months | Current |
| Latha Damle | Director | 09 Sep 2021 | 5 Years 1 Months | Current |
Auditor
Atrimed Pharmaceuticals Private Limited is audited by SHEKAR & RAJASHEKAR for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHEKAR & RAJASHEKAR | FY 2021 | 011287S |
Shareholding
The shareholding of Atrimed Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Atrimed Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.41 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Oct 2024 | 101001513 | Others | ₹2 Cr | Open | |
| 31 Oct 2022 | 100666262 | Hdfc Bank Limited | ₹41.08 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Atrimed Pharmaceuticals Private Limited has 7 court cases on record: 4 filed by Atrimed Pharmaceuticals, 3 filed against it. 2 cases are pending and 5 are disposed.
Total cases
7
Filed by the company
4
Filed against the company
3
Pending
2
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 3 | 1 |
| High courts | 2 | 0 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Court case (WP(IPD)) | Filed by the company against The Registrar of Trademark | Pending |
| District court, Kozhikode, Kerala | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Medchal Malkajgiri, Telangana | Criminal case | Filed against the company by State of Telangana Through Represented by the Drugs Inspector, Habsiguda | Disposed |
| District court, BENGALURU, Karnataka | Execution petition | Filed by the company against Ms S L S Traders | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed by the company against Ms SLS Traders | Disposed |
To see the full case history of Atrimed Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Atrimed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Atrimed Pharmaceuticals Private Limited has a workforce of 132 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
132
Active EPFO establishments
1
Employee growth
-0.75%
GST
Atrimed Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECA2885Q1ZW | Karnataka | Active | 01 Jul 2017 |
| 32AAECA2885Q2Z8 | Kerala | Active | 01 Apr 2019 |
To see the full GST registrations and return filing status of Atrimed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Atrimed Pharmaceuticals Private Limited has 7 board changes on record since 2003: 4 appointments and 3 cessations. The latest: Latha Damle ceased to be Additional Director on 30 Nov 2021.
AGM
Atrimed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Atrimed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101001513 was registered on 18 Oct 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.41 Cr with Charge ID 100666262 was registered on 31 Oct 2022.
Ceased
Latha Damle ceased to be Additional Director.
Ceased
Rishi Ganju ceased to be Additional Director.
Appointed
Latha Damle was appointed as Director.
Appointed
Rishi Ganju was appointed as Director.
Ceased
Sanjay Raj ceased to be Director.
Appointed
Ganju Shibban Krishen was appointed as Director.
Appointed
Hrishikesh Damle was appointed as Director.
Incorporation
03 Jul 2003
Atrimed Pharmaceuticals Private Limited was registered on 03 Jul 2003 with Roc Bangalore & aged 23 years 3 months as per MCA records.
Frequently asked questions
Atrimed Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 03 July 2003 (23+ years old) and is registered under CIN U02423KA2003PTC032200.
Atrimed Pharmaceuticals has 4 current directors:
- Ganju Shibban Krishen - Director
- Hrishikesh Damle - Director
- Rishi Ganju - Director
- Latha Damle - Director
The latest financial statements of Atrimed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Atrimed Pharmaceuticals is 29AAECA2885Q1ZW, registered in Karnataka. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 32AAECA2885Q2Z8 (Kerala).
The CIN (Corporate Identification Number) of Atrimed Pharmaceuticals is U02423KA2003PTC032200. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atrimed Pharmaceuticals has 7 court cases on record: 4 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Atrimed Pharmaceuticals was incorporated on 03 July 2003, making it 23+ years old. It is registered with the Registrar of Companies, Bangalore.
Latha Damle ceased to be Additional Director on 30 Nov 2021. Rishi Ganju ceased to be Additional Director on 30 Nov 2021. Latha Damle was appointed as Director on 09 Sep 2021. Atrimed Pharmaceuticals has 7 board changes on record in total.
Yes, Atrimed Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0152309).
Atrimed Pharmaceuticals can be reached through the website atrimed.com. Its registered office is in Bangalore, Karnataka, India.